CD114 _ G_CSFR _ GCSFR Antibody
- Known as:
- CD114 _ G_CSFR _ GCSFR Antibody
- Catalog number:
- 10218-MM01
- Product Quantity:
- 100
- Category:
- -
- Supplier:
- Smart Serology
- Gene target:
- CD114 _ G_CSFR GCSFR Antibody
Related genes to: CD114 _ G_CSFR _ GCSFR Antibody
- Gene:
- CSF3R NIH gene
- Name:
- colony stimulating factor 3 receptor
- Previous symbol:
- CD114
- Synonyms:
- GCSFR
- Chromosome:
- 1p34.3
- Locus Type:
- gene with protein product
- Date approved:
- 1990-12-10
- Date modifiied:
- 2019-04-23
Related products to: CD114 _ G_CSFR _ GCSFR Antibody
Related articles to: CD114 _ G_CSFR _ GCSFR Antibody
- Long-term survival of lung transplant recipients remains limited by chronic lung allograft dysfunction (CLAD). CLAD is only diagnosed following a persistent and substantial decline in lung function, after which irreversible damage to the lungs has occurred, limiting opportunities to effectively intervene at an early stage. There is a critical need for earlier detection prior to its clinical manifestation. The immunological drivers of CLAD remain unclear, limiting the development of predictive biomarkers and new therapies. - Source: PubMed
Publication date: 2026/06/23
Iacono GiuliaBegka ChristinaCardwell BaileyDaunt CarmelChatzis RoxannePattaroni CelineButler AlanaMacowan MatthewLevvey BronwynSnell Gregory IWestall Glen PMarsland Benjamin J - Uterine sarcomas are rare, heterogeneous malignancies with distinct pathological behaviors. This study aimed to identify clinicopathological characteristics, prognostic risk factors, and potential therapeutic targets to enhance clinical management. - Source: PubMed
Publication date: 2026/05/22
Huang TingXie XinyuDu XinqiaoSun XiulingZhang GuoWang Jianliu - The FUS::ERG fusion gene is rare in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), with a predominant prevalence in individuals of Asian descent. The incidence of AML harboring the FUS::ERG fusion gene is approximately 1%.Including the present case, a total of 154 cases have been reported in the literature to date.CSF3R mutation is rare in AML and frequently coexist with other genetic abnormalities to drive leukemogenesis.In this article,A case of AML harboring t(16;21)(p11.2;q22)/FUS::ERG and CSF3R mutations was retrospectively analyzed, with frequent identification of hemophagocytes and multinucleated cells in the bone marrow, and the relevant literature was reviewed. - Source: PubMed
Publication date: 2026/06/02
Chen YingyingXinhongYang Zhang ZhihuaYang Xiaofeng - To develop a new TaqMan-MGB probe based quantitative real-time polymerase chain reaction (qPCR) assay for primary screening and follow-up monitoring of colony-stimulating factor 3 receptor ( ) T618I mutation in patients with acute myeloid leukemia (AML) and chronic neutrophilic leukemia (CNL). - Source: PubMed
Liao Ming-YueLong Ling-YuJiao YaoZhao Ming-YueYan NanZhou Ya-LanHan Zhao-YueYang YangZhao Xiao-SuChang Ying-JunHuang Xiao-JunRuan Guo-Rui - Not available. - Source: PubMed
Publication date: 2026/05/14
Bolarinwa Abiola BSzuber NatashaCaron-Lecuyer JanickAl-Kali ArefHogan William JShah MithunForan James MBadar TalhaReichard Kaaren KHe RongGangat NaseemaMendoza Cinthya J ZepedaElliott Michelle APardanani AnimeshTefferi Ayalew